Start
Features
Free trial / FAQ

Researchers
Physicians
Pharmacists
Ecotrophologists
Product Managers
in Health Industries

Loading…

Medical Research Finder

Legal Notice
Privacy
Terms of Use

meRfi® Microbiome - The Digital Gut Microbiome Reference (incl. AI Chat)
Prebiotics, Probiotics, FMT / Manipulators of the Intestinal Microbiota

AuthorsReferences (Sources)

meRfi® AI Chat

Microtubule-targeting agents & Breast Cancer / Mammacarcinoma

Welcome to meRfi Microbiome!

Please register to continue your trial period!

meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.

Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.

Start your free trial and transform your understanding of the gut microbiota today!

(Login)

Navigation

Microtubule-targeting agents are key in Breast Cancer / Mammacarcinoma treatment. Taxanes are the main drugs used. Newer drugs are for resistant cases or specific subtypes. They disrupt microtubules. This causes cell division to stop and kills tumor cells. Resistance and nerve damage are big challenges (1, 2

References

(1) Wang et al. 2023 MedComm – Oncology 2: e46
(2) Uppal & Sharma 2025 Biochem Biophys Res Commun 793: 153019

…

References (Sources)

Current advancements in tubulin targeting agents for breast cancer: Design strategies, structure-activity relationships, and pharmacological insights
Uppal & Sharma 2025 Biochem Biophys Res Commun 793: 153019
Review
Microtubule-targeting agents for cancer treatment: seven binding sites and three strategies
Wang et al. 2023 MedComm – Oncology 2: e46
Review

AI Chat

7/1/2026

Chat with our artificial intelligence:

Start chat!